H.R. 7949 (119th)Bill Overview

NSF Plant Biology Act

Science, Technology, Communications|Science, Technology, Communications
Cosponsors
Support
Bipartisan
Introduced
Mar 16, 2026
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Science, Space, and Technology.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief

This bill adds a new section to the NSF Authorization Act creating competitive, merit-reviewed grants for plant and microbial biology research relevant to agriculture, food, or biotechnology.

Eligible recipients include universities, nonprofit organizations, private entities, and federal, state, local, or Tribal governments or consortia.

It authorizes $150 million per year for FY2026–2031 and amends the NSF Act's definitions to clarify nonprofit eligibility under IRC section 501(c)(3).

Passage45/100

Content is narrow and administratively straightforward, but authorization must be matched by appropriations and pass both chambers.

CredibilityPartially aligned

Relative to its intended legislative type, this bill establishes a clear statutory authorization and funding stream for NSF grants supporting plant and microbial biology research and incorporates minimal statutory integration (a definition amendment). It provides basic authority and appropriations but limited operational, oversight, and risk-mitigation detail.

Contention62/100

Whether funding primarily serves public good or private firms

02 · What it does

Who stands to gain, and who may push back.

Who this appears to help vs burden50% / 50%
Federal agencies · WorkersFederal agencies
Likely helped
  • Federal agenciesExpands federal funding for plant and microbial biology, enabling more basic and translational research projects.
  • Targeted stakeholdersIncreases development of research tools and infrastructure that accelerate agricultural biotechnology innovations.
  • WorkersBoosts collaborations between universities, industry, and government through consortia-funded projects.
Likely burdened
  • Federal agenciesAdds $150 million annually, increasing federal discretionary spending and budgetary obligations.
  • Federal agenciesCould overlap or duplicate existing USDA, DOE, or NSF plant biology programs, diluting federal coordination.
  • Targeted stakeholdersMay privilege biotechnology commercialization, potentially shifting emphasis away from noncommercial basic research.
03 · Why people split

Why the argument around this bill splits.

Whether funding primarily serves public good or private firms
Progressive80%

Generally supportive because it expands public funding for basic plant and microbial science with clear links to food security and biotechnology.

Concerned about ensuring public-interest safeguards around access, environmental impacts, and equitable benefit sharing.

Leans supportive
Centrist70%

Cautiously favorable as a targeted federal investment in science and agricultural competitiveness, but wants clearer accountability, interagency coordination, and cost oversight.

Sees merit review and competitive grants as appropriate delivery mechanisms.

Leans supportive
Conservative30%

Skeptical overall: supports basic science that boosts agriculture but worries about expanding NSF's role, recurring federal spending, and taxpayer-funded research that may advantage large private firms.

Seeks tighter limits and stronger oversight.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood45/100

Content is narrow and administratively straightforward, but authorization must be matched by appropriations and pass both chambers.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether appropriators will fund the authorized $150M annually
  • Potential overlap with USDA or existing NSF programs
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Whether funding primarily serves public good or private firms

Content is narrow and administratively straightforward, but authorization must be matched by appropriations and pass both chambers.

Unlocked analysis

Relative to its intended legislative type, this bill establishes a clear statutory authorization and funding stream for NSF grants supporting plant and microbial biology research and incorporates minimal statutory integ…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis